Advertisement
U.S. Markets closed

Sagimet Biosciences Inc. (SGMT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
5.33+0.18 (+3.50%)
At close: 04:00PM EDT
5.33 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 171.60M
Enterprise Value 5.38M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)85.05
Price/Book (mrq)0.94
Enterprise Value/Revenue 2.69
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 320.71
52 Week Low 32.13
50-Day Moving Average 33.97
200-Day Moving Average 34.86

Share Statistics

Avg Vol (3 month) 31.37M
Avg Vol (10 day) 3785.57k
Shares Outstanding 530.67M
Implied Shares Outstanding 6N/A
Float 816.2M
% Held by Insiders 114.11%
% Held by Institutions 170.09%
Shares Short (Oct 15, 2024) 43.98M
Short Ratio (Oct 15, 2024) 41.32
Short % of Float (Oct 15, 2024) 414.78%
Short % of Shares Outstanding (Oct 15, 2024) 412.37%
Shares Short (prior month Sep 13, 2024) 42.07M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,813.75%

Management Effectiveness

Return on Assets (ttm)-21.54%
Return on Equity (ttm)-29.32%

Income Statement

Revenue (ttm)2M
Revenue Per Share (ttm)0.08
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-29.25M
Diluted EPS (ttm)-0.92
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)166.37M
Total Cash Per Share (mrq)5.21
Total Debt (mrq)153k
Total Debt/Equity (mrq)0.08
Current Ratio (mrq)29.11
Book Value Per Share (mrq)5.74

Cash Flow Statement

Operating Cash Flow (ttm)-22.8M
Levered Free Cash Flow (ttm)-14.4M